Cytosorbents Corporation - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
CTSO Nasdaq 3840 www.cytosorbents.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Cytosorbents Corporation

CytoSorbents to Report Second Quarter 2026 Financial Results and Recent Business Highlights - Jul 20th, 2026 5:00 am
OTC Markets Life Sciences Investor Forum: Dr. Phillip Chan, CEO, and Pete Mariani, CFO, of CytoSorbents with Zacks SCR’s Tom Kerr, CFA - Jul 8th, 2026 4:02 am
Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing - Jun 26th, 2026 6:35 am
Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th - Jun 23rd, 2026 6:35 am
CytoSorbents to Present at the Life Sciences Forum on June 24, 2026 and Meet Virtually with Investors on June 30, 2026 - Jun 18th, 2026 6:46 am
CTSO: CytoSorbents Reports 1st Quarter Financial and Operating Results - May 21st, 2026 11:03 am
CytoSorbents Corp (CTSO) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic ... - May 13th, 2026 11:02 pm
Transcript: CytoSorbents Q1 2026 Earnings Conference Call - May 13th, 2026 3:36 pm
CytoSorbents Reports First Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update - May 13th, 2026 2:00 pm
CytoSorbents to Report First Quarter 2026 Financial Results and Recent Business Highlights - Apr 30th, 2026 5:00 am
CTSO: CytoSorbents Reports Strong 4th Quarter and Full Year 2025 Results - Apr 6th, 2026 3:42 am
Cytosorbents (CTSO) Q4 2025 Earnings Transcript - Mar 26th, 2026 8:40 am
Cytosorbents Corporation Q4 2025 Earnings Call Summary - Mar 26th, 2026 6:30 am
CytoSorbents Corp (CTSO) Q4 2025 Earnings Call Highlights: Navigating Growth and Regulatory ... - Mar 25th, 2026 9:01 pm
CytoSorbents: Q4 Earnings Snapshot - Mar 25th, 2026 2:33 pm
CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights - Mar 25th, 2026 2:03 pm
CytoSorbents Announces HotSwap™ Launch, Renewed Aferetica Partnership, and New Clinical Evidence at ISICEM 2026 - Mar 19th, 2026 7:30 am
CytoSorbents to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights - Mar 5th, 2026 5:00 am
Analysts Expect Breakeven For Cytosorbents Corporation (NASDAQ:CTSO) Before Long - Feb 14th, 2026 5:16 am
CTSO: CytoSorbents Price Target Increased to $5.00 Based on Higher Than Expected Gross Margins - Jan 13th, 2026 6:08 am